Interferon and ribavirin treatment in a rhesus macaque model of novel Middle East respiratory syndrome coronavirus (MERS-CoV) infection (hCoV-EMC)
Ontology highlight
ABSTRACT: Microarray analysis of lungs (right lower lobe) on day 3 post-infection with MERS-CoV with and without treatment beginning 8 h post-infection with intravenous type I interferon (IFN) and ribavirin (RBV). Dosages are as follows: IFN a2b 5 million IU/kg s.c. q8, RBV loading dose 30mg/kg i.v.; Maintenance doses: IFN 5 MIU/kg s.c. q16; RBV, 10mg/kg i.m. q8.
ORGANISM(S): Macaca mulatta
PROVIDER: GSE47957 | GEO | 2013/09/06
SECONDARY ACCESSION(S): PRJNA208496
REPOSITORIES: GEO
ACCESS DATA